AzTrials
AzTrials

Neonatal Intensive CareOREANENCT03036449

Efficacy of a Multifaceted Intervention to Reduce Medication Administration Errors in Neonatal Intensive Care Units

An observational study of Neonatal Intensive Care, run by University Hospital, Bordeaux at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether an educational program for caregivers associated with convenient tools is effective to reduce medication preparation and administration errors in the Neonatal Intensive Care Units (NICU). Read more about this study

Who is it for?
Ages Up to 2 years
Conditions the study is for
Neonatal Intensive Care
What is being tested?
Education program for NICU caregivers.
How many people
5,143 participants
Where
3 sitesFrance
Study dates
13 Nov 2017to 17 Mar 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Patients less than 2 years old, hospitalized in the intensive care during the observation periods and receiving drugs.

Who may be able to join

  • All nurses working in the intensive care units in the day time.

Who cannot join

  • Nurses working as a float or pool nurses.
  • Nurses working at night.

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Service de pédiatrie - Hôpital Pellegrin

    Bordeaux, 33000

  • CHU Côte de Nacre

    Caen, 14033

  • CHU de Rouen

    Rouen, 76031

Other trials in France

About this study

Official title: Efficacy of Tools Associated With a Multifaceted Education Intervention Directed to Health Professionals to Reduce Medication Preparation and Administration Error Rates in Neonatal Intensive Care Units

The purpose of this study is to determine whether an educational program for caregivers associated with convenient tools is effective to reduce medication preparation and administration errors in the Neonatal Intensive Care Units (NICU).

Read the detailed description

Medication errors are frequent in neonatal intensive care units and consequences are more severe than in adults. Although errors happen in each step of medication management process, a large proportion of errors occur during medication preparation and administration.

This study will test the hypothesis that rates of medication errors during preparation and administration will be reduced by implementing an education program for NICU caregivers (Nurses) and providing convenient tools.

The trial has a stepped wedge design, in which the NICU's from three hospitals in France will be randomized (Group A, B and C) to the timing of implementation of the educational intervention.

According to the allocation (Group A, B or C), the education intervention will include a complete main program of nine weeks and one to three maintenance educational periods.

Medication administration errors rates will be measured before (baseline measurements) and after each educational interventions (main or maintenance interventions).

Errors will be identified by direct observations of nurse's acts by external observers.

Being tested
Education program for NICU caregivers.
Keywords
Medication errors, Patient safety

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Education program for NICU caregivers.Behavioural

    Intervention includes a main initial educational program, maintenance education programs and tools supply

    • Main educational program will include 9 hours of courses into NICU (1 hour each week) and @ learning modules validation.

    Topics: Main causes of medication errors, How to analyse retrospectively medication errors, Strategies to reduce medication errors, How to improve communication between health professional; Task interruption; Standardisation of preparation…..

    • Maintenance education program will return on specific topics of main program and will be fitted to each NICU needs.
    • Examples of Tools: check lists, medication neonatal formulary, "Sound alike" and "Look alike" drug lists…
Study groups in NCT03036449
Study groupRoleWhat they receive
AGroup A: Phase 1: Observations (Baseline rate of errors); Phase 2: Main Educational program; Phase 3: Observations; Phase 4: Maintenance Educational program; Phase 5: Observations; Phase 6: Maintenance Educational program; Phase 7: Observations; Phase 8: Maintenance Educational program; Phase 9: Observations.
Receives: Behavioral: Education program for NICU caregivers.
BGroup B: Phase 1: Observations (Baseline rate of errors); Phase 2: No intervention; Phase 3: Observations (Baseline rate of errors); Phase 4: Main Educational program; Phase 5: Observations; Phase 6: Maintenance Educational program; Phase 7: Observations; Phase 8: Maintenance Educational program; Phase 9: Observations.
Receives: Behavioral: Education program for NICU caregivers.
CGroup C: Phase 1: Observations (Baseline rate of errors); Phase 2: No intervention; Phase 3: Observations (Baseline rate of errors); Phase 4: No intervention; Phase 5: Observations (Baseline rate of errors); Phase 6: Main educational program; Phase 7: Observations; Phase 8: Maintenance educational program; Phase 9: Observations.
Receives: Behavioral: Education program for NICU caregivers.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Medication administration error rates in the patients

    Assessment of the efficacy of the intervention on reducing the rates of medication administration errors.

    Error rate: Number of identified errors/Number of observed acts of administration*100, measured by direct observation of nurse's acts by specifically trained external observers.

    Measured: Baseline and up to 49 weeks

Secondary outcomes (3)
  1. Levels of safety culture among the caregivers (Nurses)

    Assessment of the effectiveness of the educational intervention on increasing safety culture measured using Hospital Survey on patient safety.

    Measured: Baseline and up to 49 weeks

  2. Levels of medication errors reported by caregivers.

    Assessment of the efficacy of the educational intervention to increase voluntary reporting of medication errors by caregivers.

    Measured: Baseline and up to 49 weeks

  3. Acceptance of the educational program

    Assessment of acceptance by satisfaction questionnaire

    Measured: Baseline and up to 49 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2017 (estimated)
  2. Study start13 Nov 2017
  3. Primary completion17 Mar 2019
  4. Study completion17 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
5,143 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03036449
Sponsor's protocol ID
CHUBX 2014/38
Acronym
OREANE
Status last verified
May 2020
First submitted
23 Dec 2016
Last updated
13 May 2020
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Neonatal Intensive Care, run by University Hospital, Bordeaux at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Medication administration error rates in the patients (time frame: Baseline and up to 49 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in